CTS (CTS) Sidoti Small-Cap Virtual Conference summary

Strategic focus and business overview

• Emphasis on diversification and electrification, targeting growth in medical, industrial, aerospace, and defense markets while maintaining a strong transportation segment.

• Portfolio is powertrain agnostic, supporting both traditional and electric vehicles.

• Strong balance sheet with leverage below 1, supporting organic growth and acquisitions.

• Revenue breakdown: 60% North America, 15% Europe, 26% Asia (largest in China).

• Diversified non-transportation markets made up 56% of Q4 2024 revenue.

Market trends and growth drivers

• Growth propelled by automation, healthcare innovation (minimally invasive applications), and electrification.

• Industrial market applications include HVAC, smart metering, and industrial printing.

• Medical market growth driven by minimally invasive procedures, ultrasound, and therapeutics.

• Aerospace and defense revenue up 37% to $70M, with mid-single-digit growth expected.

• Transportation market faces headwinds in China and commercial vehicles, but focus remains on sensors and actuators for all powertrains.

Operational performance and financials

• Targeting 10% annual growth: 5% organic, 5% via acquisitions.

• Gross margin improved to 37% in the last 12 months, aiming for 38% long-term.

• SG&A expenses in the 13%-15% range, R&D at 5%-6% of revenue, CapEx around 4%.

• Returned $238M to shareholders; 60%-80% of free cash flow allocated to acquisitions.

• 2025 revenue guidance: $520M-$550M, with EPS expected to improve year-over-year.